U.S. President Donald Trump participates in a bilateral assembly with Finland’s President Alexander Stubb (not pictured), within the Oval workplace on the White Home in Washington, D.C., U.S., Oct. 9, 2025.
Nathan Howard | Reuters
The Trump administration and AstraZeneca introduced Friday they’ve reached an settlement for the U.Okay.-based pharmaceutical large to chop drug costs within the U.S.
The cope with AstraZeneca follows an analogous pact with U.S. drugmaker Pfizer, which was introduced late final month.
AstraZeneca will comply with promote medication on to Medicaid sufferers on the lowest worth supplied in different developed international locations, or what Trump calls “most-favored nation” pricing, on a coming authorities web site referred to as TrumpRx.gov. AstraZeneca’s main care medicines will probably be accessible on the positioning beginning early subsequent yr, and the corporate will supply new prescription medicines at most-favored nation pricing, stated Facilities for Medicare & Medicaid Providers Administrator Mehmet Oz.
AstraZeneca CEO Pascal Soriot additionally stated the corporate will probably be exempt from pharmaceutical sector tariffs as a part of the settlement. Pfizer agreed to related phrases with the Trump administration and obtained a three-year carveout from pharmaceutical tariffs on the situation that it continued to spend money on U.S. manufacturing.
AstraZeneca in July stated it could make investments $50 billion within the U.S. by 2030. The corporate introduced additional particulars about these plans Friday forward of the reported pricing deal announcement.
President Donald Trump, administration officers and Soriot introduced the settlement throughout a White Home occasion on Friday.
MSNBC earlier reported on the deal.
Trump has pushed drugmakers to chop costs and construct out manufacturing within the U.S., as sky-high prices for medicines relative to different developed international locations irk voters throughout the political spectrum. As his administration threatened pharmaceutical corporations with tariffs as excessive as 250% in latest months, many drugmakers introduced vital investments within the U.S.
Trump has stated he goals to strike pricing offers with different main drugmakers within the weeks forward. Trump advised drugmakers and different corporations have invested as a lot as they did due to the specter of increased tariff prices.
“Most of them are right here due to tariffs,” he stated.